Disentangling Causal Substructures for Interpretable and Generalizable Drug Synergy Prediction

• URL: http://arxiv.org/abs/2511.02146v1
• Date: Tue, 04 Nov 2025 00:32:20 GMT
• Title: Disentangling Causal Substructures for Interpretable and Generalizable Drug Synergy Prediction
• Authors: Yi Luo, Haochen Zhao, Xiao Liang, Yiwei Liu, Yuye Zhang, Xinyu Li, Jianxin Wang,
• Abstract summary: CausalDDS is a novel framework that disentangles drug molecules into causal and spurious substructures.<n>CaulDDS effectively identifies key substructures underlying drug synergy.
• Score: 24.633440135682605
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Drug synergy prediction is a critical task in the development of effective combination therapies for complex diseases, including cancer. Although existing methods have shown promising results, they often operate as black-box predictors that rely predominantly on statistical correlations between drug characteristics and results. To address this limitation, we propose CausalDDS, a novel framework that disentangles drug molecules into causal and spurious substructures, utilizing the causal substructure representations for predicting drug synergy. By focusing on causal sub-structures, CausalDDS effectively mitigates the impact of redundant features introduced by spurious substructures, enhancing the accuracy and interpretability of the model. In addition, CausalDDS employs a conditional intervention mechanism, where interventions are conditioned on paired molecular structures, and introduces a novel optimization objective guided by the principles of sufficiency and independence. Extensive experiments demonstrate that our method outperforms baseline models, particularly in cold start and out-of-distribution settings. Besides, CausalDDS effectively identifies key substructures underlying drug synergy, providing clear insights into how drug combinations work at the molecular level. These results underscore the potential of CausalDDS as a practical tool for predicting drug synergy and facilitating drug discovery.

Related papers

• Latent Causal Diffusions for Single-Cell Perturbation Modeling [83.47931153555321]
  We present a generative model that frames single-cell gene expression as a stationary diffusion process observed under measurement noise.<n> LCD outperforms established approaches in predicting the distributional shifts of unseen perturbation combinations in single-cell RNA-sequencing screens.<n>We develop an approach we call causal linearization via perturbation responses (CLIPR), which yields an approximation of the direct causal effects between all genes.
  arXiv  Detail & Related papers  (2026-01-20T16:15:38Z)
• MolBridge: Atom-Level Joint Graph Refinement for Robust Drug-Drug Interaction Event Prediction [10.392084347375963]
  Drug combinations offer therapeutic benefits but also carry the risk of adverse drug-drug interactions (DDIs)<n>This work contributes to Web Mining and Content Analysis by developing graph-based methods for mining and analyzing drug-drug interaction networks.
  arXiv  Detail & Related papers  (2025-10-23T11:33:16Z)
• Generative Intervention Models for Causal Perturbation Modeling [80.72074987374141]
  In many applications, it is a priori unknown which mechanisms of a system are modified by an external perturbation.<n>We propose a generative intervention model (GIM) that learns to map these perturbation features to distributions over atomic interventions.
  arXiv  Detail & Related papers  (2024-11-21T10:37:57Z)
• Towards Understanding the Robustness of Diffusion-Based Purification: A Stochastic Perspective [65.10019978876863]
  Diffusion-Based Purification (DBP) has emerged as an effective defense mechanism against adversarial attacks.<n>In this paper, we propose that the intrinsicity in the DBP process is the primary factor driving robustness.
  arXiv  Detail & Related papers  (2024-04-22T16:10:38Z)
• DTIAM: A unified framework for predicting drug-target interactions, binding affinities and activation/inhibition mechanisms [9.671391525450716]
  We introduce a unified framework called DTIAM, which aims to predict interactions, binding affinities, and activation/inhibition mechanisms between drugs and targets. DTIAM learns drug and target representations from large amounts of label-free data through self-supervised pre-training. It achieves substantial performance improvement over other state-of-the-art methods in all tasks, particularly in the cold start scenario.
  arXiv  Detail & Related papers  (2023-12-23T13:27:41Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• Interpreting the Mechanism of Synergism for Drug Combinations Using Attention-Based Hierarchical Graph Pooling [10.898133007285638]
  We develop an interpretable graph neural network (GNN) that reveals the underlying essential therapeutic targets and the mechanism of the synergy (MoS) The proposed GNN model provides a systematic way to predict and interpret the drug combination synergism based on the detected crucial sub-molecular network.
  arXiv  Detail & Related papers  (2022-09-19T11:18:45Z)
• Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction [10.157966744159491]
  Concomitant administration of drugs can cause drug-drug interactions (DDIs) We propose a novel model, Molecular Substructure-Aware Network (MSAN), to effectively predict potential DDIs from molecular structures of drug pairs.
  arXiv  Detail & Related papers  (2022-08-24T02:06:21Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• Multi-View Substructure Learning for Drug-Drug Interaction Prediction [69.34322811160912]
  We propose a novel multi- view drug substructure network for DDI prediction (MSN-DDI) MSN-DDI learns chemical substructures from both the representations of the single drug (intra-view) and the drug pair (inter-view) simultaneously and utilizes the substructures to update the drug representation iteratively. Comprehensive evaluations demonstrate that MSN-DDI has almost solved DDI prediction for existing drugs by achieving a relatively improved accuracy of 19.32% and an over 99% accuracy under the transductive setting.
  arXiv  Detail & Related papers  (2022-03-28T05:44:29Z)
• DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations [0.9854322576538699]
  computational screening has become an important way to prioritize drug combinations. DeepDDS was superior to competitive methods by more than 16% predictive precision.
  arXiv  Detail & Related papers  (2021-07-06T08:25:43Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.